Patch Pump Applications

Whitepaper

Treatments for pain or oncology drugs often use pump systems in the beginning. However, not only is time and cost of the essence, the potential of an overall increased treatment result combined with lower side-effects is more and more considered for new drug applications by the pharmaceutical community.

Large Volume Device Patch Pumps have to be small yet still incorporating all functions including a pump system, a needle insertion system, a battery, a drive, and an electronic control unit. The device needs to be patched to the body offering the patient discreet use.

Preferably equipped with a soft cannula, the patient can enjoy total freedom to move, wear comfort and safety after removal as the risk of needle stick injuries which is eliminated.

Download this free whitepaper to find out more about patch pump uses.

Patch Pump Applications

For Free, instant access, click below.

Download Whitepaper

First Name*

Last Name*

Email*

Role In Purchasing*

Reason For Download*

Job Title*

Job Function*

Company*

Company Activity*

Country*

Telephone number*

I have read and accept the terms and conditions and privacy policy.

We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.

If you would like to hear from carefully selected third party companies, check this box

Follow this company to receive notifications when they update.

Thank You

Your white paper is now downloading... Click here if the download does not begin.

Clinical Trials

After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics

Fasinumab Phase III osteoarthritis trial meets endpoints

EMA gives PRIME status to promising Huntington’s treatment

Cold Chain

EMA gives PRIME status to promising Huntington’s treatment

UK seeks harmony with EU CTR as NHS and pharma stockpile drugs

Pharma air freight: what does it take to get certified?

Diseases

NUI Galway finds new treatment strategy for breast cancer relapse

BioNTech signs $425m flu vaccine deal with Pfizer

RXi and Karolinska Institutet target solid tumour therapy

Drug Development

So you want to break into the Chinese vaccine market?

Revlimid demonstrates positive phase III results in Indolent NHL

Fasinumab Phase III osteoarthritis trial meets endpoints

Manufacturing

So you want to break into the Chinese vaccine market?

After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics

Big soil: Genentech and Lodo launch $1bn project to develop new drugs from earth

Market Data

So you want to break into the Chinese vaccine market?

Revlimid demonstrates positive phase III results in Indolent NHL

Deals and M&As this week: Aralez Pharmaceuticals, Perrigo, Takeda

Obsessions

Hackers can fool doctors with fake vital signs, but only the rich and powerful need to worry

Human-level intelligent machines will arrive in a decade: Technology industry veteran

UK attempts to plug STEM skills shortage with science visa scheme

Whitepaper